U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Guidance, Compliance, & Regulatory Information
  4. Surveillance: Post Drug-Approval Activities
  5. FDA's Adverse Event Reporting System (FAERS)
  6. Archived Reports | Potential Signals of Serious Risks/New Safety Information Identified from the FDA Adverse Event Reporting System (FAERS) (formerly AERS)
  1. FDA's Adverse Event Reporting System (FAERS)

Archived Reports | Potential Signals of Serious Risks/New Safety Information Identified from the FDA Adverse Event Reporting System (FAERS) (formerly AERS)

The following reports list potential signals of serious risks/new safety information that were identified using the FAERS database during the indicated quarter. Data from AERS was moved to FAERS for the launch of FAERS on September 10, 2012.

After FDA has either determined that no regulatory action is required or has taken a regulatory action for each issue on a quarterly report, we will stop updating it and will add it to the list of archived reports on this page.


Archived Quarterly Reports

FDA is no longer updating these reports.

2019

2016

2015

2014

2013

2012

2011

2010

2009

2008

Back to Top

Back to Top